Astrocyte-Specific Upregulation of Tumor Necrosis Factor Receptor II Ameliorates Pathological Phenotypes in APPNL-F/NL-F Mice
Neuroscience Bulletin · 2026-11 · 42 (11) · 2431-2450
DOI: 10.1007/s12264-026-01593-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroscience Bulletin, online erschienen am 11.03.2026. Verfasst von Dafeng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, I'nstitute on Aging and Brain Disorders, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, Univ…. Hauptthemen laut MEDLINE: Astrocytes, Alzheimer Disease, Receptors, Tumor Necrosis Factor, Type II. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Our earlier research showed that deletion of tumor necrosis factor-α receptor II (TNFRII) exacerbated Alzheimer's disease (AD) associated pathology in the AD mouse model. Previous studies have demonstrated that TNFRII was mainly expressed in astrocytes. However, whether AD-associated pathology can be modified by targeting TNFRII in astrocytes remains unknown. Here, we showed that TNFRII was decreased in astrocytes in AD brains. Then, we developed transgenic mouse models (astrocyte-specific expression of human TNFRII mice, TNFRIIGFAP mice) and crossed TNFRIIGFAP mice with a mouse model of AD (humanized APP knock-in mice, APPNL-F/NL-F mice). We found that increased expression of TNFRII in astrocytes rescued learning and memory deficits, decreased amyloid burden, and reactive astrocytes in APPNL-F/NL-F mice. Mechanistically, APPNL-F/NL-F-TNFRIIGFAP mice displayed increased microgliosis, higher expression of plaque-associated microglial cluster of differentiation 68 (CD68), and enhanced microglial amyloid-β (Aβ) phagocytosis. In vitro assays confirmed that TNFRII upregulation in astrocytes enhanced phagocytosis of Aβ in BV2 murine microglial cell line (BV2) cells. Our study implicates that increased expression of TNFRII in astrocytes ameliorates pathology and behavioral deficits in APPNL-F/NL-F mice and provides new therapeutic options for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, I'nstitute on Aging and Brain Disorders, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230026, China.
- Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China.
- Anhui Province Key Laboratory of Biomedical Aging Research, Hefei, 230036, China.
- Department of Neurology, I'nstitute on Aging and Brain Disorders, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230026, China. yongs…
- Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China. yongshen@ustc.edu.cn.
- Anhui Province Key Laboratory of Biomedical Aging Research, Hefei, 230036, China. yongshen@ustc.edu.cn.
Zitieren
APA
Li, D., Li, Y., Wen, L., Chen, Z., Gao, F., Shen, Y., & Wang, Q. (2026). Astrocyte-Specific Upregulation of Tumor Necrosis Factor Receptor II Ameliorates Pathological Phenotypes in APPNL-F/NL-F Mice. Neuroscience Bulletin, 42(11), 2431-2450. https://doi.org/10.1007/s12264-026-01593-7
Vancouver
Li D, Li Y, Wen L, Chen Z, Gao F, Shen Y, et al. Astrocyte-Specific Upregulation of Tumor Necrosis Factor Receptor II Ameliorates Pathological Phenotypes in APPNL-F/NL-F Mice. Neuroscience Bulletin. 2026;42(11):2431-2450. doi:10.1007/s12264-026-01593-7
BibTeX
@article{Li2026,
author = {Li, Dafeng and Li, Yang and Wen, Lang and Chen, Zuolong and Gao, Feng and Shen, Yong and Wang, Qiong},
title = {Astrocyte-Specific Upregulation of Tumor Necrosis Factor Receptor II Ameliorates Pathological Phenotypes in APPNL-F/NL-F Mice},
journal = {Neuroscience Bulletin},
year = {2026},
volume = {42},
number = {11},
pages = {2431--2450},
doi = {10.1007/s12264-026-01593-7}
}
EUVIMED